Grantham, Mayo, Van Otterloo & Co (GMO)’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-42,784
| Closed | -$14.1M | – | 628 |
|
|
2024
Q4 | $14.1M | Sell |
42,784
-40,015
| -48% | -$13.6M | 0.05% | 225 |
|
|
2024
Q3 | $27.7M | Sell |
82,799
-13,334
| -14% | -$4.23M | 0.09% | 158 |
|
|
2024
Q2 | $26.3M | Buy |
96,133
+2,781
| +3% | +$809K | 0.09% | 152 |
|
|
2024
Q1 | $32.3M | Sell |
93,352
-5,738
| -6% | -$1.89M | 0.12% | 126 |
|
|
2023
Q4 | $32M | Buy |
99,090
+16,647
| +20% | +$5.22M | 0.14% | 125 |
|
|
2023
Q3 | $29.6M | Buy |
82,443
+5,339
| +7% | +$2.06M | 0.14% | 134 |
|
|
2023
Q2 | $29.2M | Buy |
77,104
+11,704
| +18% | +$4.76M | 0.14% | 133 |
|
|
2023
Q1 | $31.3M | Sell |
65,400
-1,800
| -3% | -$843K | 0.16% | 132 |
|
|
2022
Q4 | $28.3M | Buy |
67,200
+10,800
| +19% | +$4.36M | 0.15% | 137 |
|
|
2022
Q3 | $23.5M | Buy |
56,400
+2,700
| +5% | +$1.35M | 0.14% | 166 |
|
|
2022
Q2 | $26.6M | Buy |
53,700
+9,200
| +21% | +$4.79M | 0.14% | 148 |
|
|
2022
Q1 | $25.1M | Buy |
44,500
+15,400
| +53% | +$9.28M | 0.12% | 163 |
|
|
2021
Q4 | $22M | Buy |
29,100
+6,500
| +29% | +$4.86M | 0.11% | 161 |
|
|
2021
Q3 | $16.9M | Buy |
22,600
+3,000
| +15% | +$2.25M | 0.08% | 189 |
|
|
2021
Q2 | $12.6M | Buy |
+19,600
| New | +$11.9M | 0.06% | 222 |
|
|
2019
Q2 | – | Sell |
-2,200
| Closed | -$672K | – | 707 |
|
|
2019
Q1 | $672K | Sell |
2,200
-100
| -4% | -$27K | ﹤0.01% | 539 |
|
|
2018
Q4 | $534K | Hold |
2,300
| – | – | ﹤0.01% | 427 |
|
|
2018
Q3 | $720K | Sell |
2,300
-300
| -12% | -$93.1K | 0.01% | 410 |
|
|
2018
Q2 | $750K | Hold |
2,600
| – | – | 0.01% | 408 |
|
|
2018
Q1 | $650K | Buy |
2,600
+100
| +4% | +$25.5K | ﹤0.01% | 437 |
|
|
2017
Q4 | $597K | Buy |
+2,500
| New | +$606K | ﹤0.01% | 444 |
|
Other funds holding BIO
VAM
AI
